awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33421108-5505F76B-4B22-43C8-BDED-740FD00FEDD4
Q33421108-5505F76B-4B22-43C8-BDED-740FD00FEDD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421108-5505F76B-4B22-43C8-BDED-740FD00FEDD4
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.
P2860
Q33421108-5505F76B-4B22-43C8-BDED-740FD00FEDD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421108-5505F76B-4B22-43C8-BDED-740FD00FEDD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad015041e685d8980d50e382e8c119e860faa631
P2860
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).